4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000150
EVP, Chief Scientific Officer sold 54 shares at $430.93 ($23,270)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ALTSHULER DAVID · EVP, Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-15 | Sale : show line 1 in the form 10b5-1 | −54 | $430.93 | $23,270 | 25,813 | D |
| Open-market sales · 54 sh · avg $430.93 · $23,270 | ||||||
Loading xslF345X05/wk-form4_1715977306.xml…